Sommaire

Numéro précédent | Numéro suivant

• • ·Editorial board

    Page :A1

    
• • ·Table of contents

    Page :A3

    
• • ·Information for readers

    Page :A24

    
• • ·JAAD Case Reports article list

    Page :A25

    
• • ·Journal based CME instructions and information

    Page :A28

    

• Continuing Medical Education

  • ·Psoriatic arthritis: A comprehensive review for the dermatologist part I: Epidemiology, comorbidities, pathogenesis, and diagnosis

    Page :969-982

    Lourdes M. Perez-Chada, Scott Elman, Camila Villa-Ruiz, April W. Armstrong, Alice B. Gottlieb, Joseph F. Merola

    Résumé Résumé Plan Plan  
  • ·CME examination

    Page :983

    
  • ·Answers to CME examination

    Page :984

    
  • ·Psoriatic arthritis: A comprehensive review for the dermatologist–Part II: Screening and management

    Page :985-998

    Scott A. Elman, Lourdes M. Perez-Chada, April Armstrong, Alice B. Gottlieb, Joseph F. Merola

    Résumé Résumé Plan Plan  
  • ·CME examination

    Page :999

    
  • ·Answers to CME examination

    Page :1000

    

• Letter from the Editor

  • ·Lab monitoring – Choose wisely

    Page :1001-1002

    Dirk M. Elston

    

• This Month in JAAD

  • ·This Month in JAAD: May 2025

    Page :1003

    Dirk M. Elston

    

• This Month in JAAD Case Reports

  • ·This Month in JAAD Case Reports: May 2025

    Page :1004

    Abby Susan Van Voorhees

    

• This Month in JAAD International

  • ·This month in JAAD International: May 2025: Body dysmorphic disorder and the theoretical underpinnings of a complex disease

    Page :1005

    Jonathan Kantor

    

• This Month in JAAD Reviews

  • ·This Month in JAAD Reviews: May 2025—Suicide and Dermatology

    Page :1006-1007

    Shari R. Lipner

    

• A Clinician's Perspective

  • ·Going toe-to-toe in treating interdigital tinea pedis

    Page :1008-1009

    Warren R. Heymann

    

• Original Articles

  • ·Long-term evolution of prepubertal-onset anogenital lichen sclerosus: A 35-year retrospective and cross-sectional study from a single tertiary care maternal and pediatric center

    Page :1010-1014

    Sheila Vallée, Violaine Deneux, Deana Funaro, Danielle Marcoux, Julie Powell, Afshin Hatami, Jérôme Coulombe, Maryam Piram, Catherine Cameron McCuaig

    Résumé Résumé Plan Plan
  • ·Risk of major adverse cardiovascular events and venous thromboembolic events between patients with psoriasis or psoriatic arthritis on tumor necrosis factor inhibitors, interleukin 17 inhibitors, interleukin 12/23 inhibitors, and interleukin 23 inhibitors: An emulated target trial analysis

    Page :1015-1023

    Tai-Li Chen, Jing-Yang Huang, Hui-Yun Lin, Yun-Ting Chang, Cheng-Yuan Li, James Cheng-Chung Wei

    Résumé Résumé Plan Plan  
  • ·The efficacy of longer-term lebrikizumab treatment in patients with moderate-to-severe atopic dermatitis who did not meet protocol-defined response criteria at week 16 in 2 randomized controlled clinical trials

    Page :1024-1031

    Emma Guttman-Yassky, David Rosmarin, Marjolein de Bruin-Weller, Stephan Weidinger, Thomas Bieber, H. Chih-ho Hong, Hany Elmaraghy, Amber Reck Atwater, Evangeline Pierce, Chenjia Xu, Helena Agell, Esther Garcia Gil, Eric Simpson

    Résumé Résumé Plan Plan  
  • ·Effect of finger socks on clinical cure in interdigital tinea pedis

    Page :1032-1038

    Hasan Aksoy, Mehmet Salih Gurel, Abdurrahman Sarmış, Müge Aslan

    Résumé Résumé Plan Plan  

• JAAD Game Changers

  • ·JAAD Game Changers: Pediatric melanomas often mimic benign skin lesions: A retrospective study

    Page :1038

    Eden Lake

    

• Original Articles

  • ·Interferon-α biological activity is associated with disease activity and risk of flare in cutaneous lupus erythematosus: A monocentric study of 184 patients

    Page :1039-1048

    Quitterie Murat de Montai, Clémence Masseran, Laura Perray, Alexis Mathian, Karim Dorgham, Guy Gorochov, Alexandre Teboul, Camille Francès, Laurent Arnaud, Annick Barbaud, Zahir Amoura, Caroline Charre, François Chasset

    Résumé Résumé Plan Plan  
  • ·A 96-week real-world outcome of upadacitinib treatment for atopic dermatitis: Systemic therapy-naive versus -experienced patients

    Page :1049-1055

    Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

    Résumé Résumé Plan Plan  
  • ·Predictors of perceived stress, perceived stigmatization, and body dysmorphia in patients with chronic prurigo/prurigo nodularis: Results from an observational cross-sectional multicenter European study in 17 countries

    Page :1056-1063

    Anne-Sophie Ficheux, Emilie Brenaut, Christina Schut, Florence J. Dalgard, Anthony Bewley, Henriet van Middendorp, Uwe Gieler, Lars Lien, Francesca Sampogna, Sonja Ständer, Lucia Tomas-Aragones, Nienke Vulink, Andrew Y. Finlay, Franz J. Legat, Géraldine Titeca, Gregor B. Jemec, Csanád Szabó, Vesna Grivcheva-Panovska, Saskia Spillekom-van Koulil, Flora Balieva, Jacek C. Szepietowski, Adam Reich, Barbara R. Ferreira, Andrey Lvov, Dmitry Romanov, Servando E. Marron, Tamara Gracia-Cazaña, Åke Svensson, Ilknur K. Altunay, Andrew R. Thompson, Claudia Zeidler, Jörg Kupfer, Laurent Misery

    Résumé Résumé Plan Plan
  • ·Prevalence of poor outcomes in cutaneous squamous cell carcinoma by AJCC and BWH tumor stages: A systematic review and meta-analysis

    Page :1064-1071

    George A. Zakhem, Sultan Qiblawi, Eva Shelton, Yaohui Gloria Xu

    Résumé Résumé Plan Plan  

• Dermatologic Surgery

  • ·Nail unit melanoma treated with Mohs micrographic surgery: Technique, local recurrence rate, and surgical outcomes

    Page :1072-1079

    Karla L. Valdes Morales, Daniela Frankel, Mara D. Trifoi, Stephanie K. Lin, Annika M. Deitermann, Marissa Lubeck, Joseph F. Sobanko, H. William Higgins, Cerrene N. Giordano, Joanna L. Walker, Junqian Zhang, Daniel J. Lewis, Benjamin Chang, Jason D. Wink, Ines C. Lin, Stephen J. Kovach, Jeremy R. Etzkorn, Christopher J. Miller

    Résumé Résumé Plan Plan

• JAAD Game Changers

  • ·JAAD Game Changers: Propranolol treatment of infantile hemangioma (IH) is not associated with developmental risk or growth impairment at age 4 years

    Page :1079

    Eden Lake

    

• Brief Reports

  • ·Infrequent laboratory abnormalities during terbinafine therapy for onychomycosis: A retrospective cohort analysis within an integrated health system

    Page :1080-1082

    Kurt S. Wenk, Xinxie Wu, Michael J. Miller

    
  • ·Current evidence on safety of Janus kinase inhibitors in pregnancy and lactation

    Page :1082-1084

    Emily R. Gordon, Mitchell Hanson, Tina Bhutani, Natasha A. Mesinkovska

     
  • ·Long-term effectiveness and safety assessment of carbon dioxide laser treatment in Hailey-Hailey disease: A prospective cohort study

    Page :1084-1086

    Javier Antoñanzas, Rafael Salido-Vallejo, Jorge María Núñez-Córdoba, Agustín España, Leyre Aguado

     
  • ·Limited efficacy of platelet-rich plasma intramatricial injections for idiopathic brittle nail treatment: A pilot intrasubject randomized controlled trial

    Page :1086-1088

    Jose W. Ricardo, Chander Grover, Matilde Iorizzo, Bianca M. Piraccini, Yuqing Qiu, Shari R. Lipner

    
  • ·Stigma underlies the mental health burden of pediatric atopic dermatitis: A cohort study

    Page :1088-1091

    Sheshanna Phan, Aleena Hajek, Stephanie M. Rangel, Ziyou Ren, David Cella, Jin-Shei Lai, Amy S. Paller

    Plan Plan
  • ·The spectrum of cutaneous and systemic manifestations associated with anti-PM/Scl: Insights from a single institution case series

    Page :1091-1093

    Sabrina M. Saeed, Jeff R. Gehlhausen, Fotios Koumpouras, Sarika Ramachandran

    
  • ·Real-world experience of bimekizumab for plaque psoriasis in adult patients with prior exposure to interleukin-17 inhibitors: A 52-week multicenter retrospective review

    Page :1093-1095

    Siddhartha Sood, Alexander Rimke, Brian D. Rankin, Abrahim Abduelmula, Jorge R. Georgakopoulos, Khalad Maliyar, Ahmed Bagit, Fernejoy Leung, Alim R. Devani, Ronald Vender, Jensen Yeung, Vimal H. Prajapati

    
  • ·Overall and subgroup prevalences of noninfectious uveitis among patients with hidradenitis suppurativa

    Page :1096-1098

    Bria Midgette, Andrew Strunk, Robert Sabat, Kerstin Wolk, Amit Garg

    
  • ·Risk of interstitial lung disease in adult patients with dermatomyositis treated with methotrexate: A retrospective analysis of a prospective cohort

    Page :1098-1100

    Catherine Z. Shen, Hallie Carol, Rui Feng, Alannah Hill, Lais Lopes Almeida Gomes, Emily Z. Hejazi, Victoria P. Werth, Katharina S. Shaw

    
  • ·Black patients with Mycosis fungoides and Sézary Syndrome experience worse health-related quality of life: A cross-sectional study

    Page :1100-1102

    Anise Marshall, Shamey Kassim, Jessica Brown-Korsah, Caroline Raymundo, Corey Chang, Daniel S. Hippe, Ellen J. Kim, Michi M. Shinohara

    
  • ·Affordability matters: A cross-sectional study on sunscreen cost and application amount

    Page :1103-1104

    Kristen Fernandez, Jeffrey Schneider, Dan Moore, Benjamin V. Wu, Arjun Johal, Maria L. Wei

     
  • ·A comparison of iPLEDGE requirements to risk mitigation programs for isotretinoin in other countries and to other teratogenic medications in the United States

    Page :1104-1107

    Nikita Menta, Nidhi Shah, A. Yasmine Kirkorian

    
  • ·Safety of beta blockers for the treatment of PHACE syndrome: A systematic review

    Page :1107-1109

    Alexandra Finstad, Yuliya Lytvyn, Elena Pope, Cathryn Sibbald

     
  • ·Limited and variable access to dermatologists among medicaid beneficiaries in the United States

    Page :1109-1112

    Sarah Dickerman, Christian Gronbeck, Eric Beltrami, Seda Sahin, Jipeng Yue, Vijay Kodumudi, Jane M. Grant-Kels, Hao Feng

     
  • ·Development of a treatment decision aid for patients with dysplastic nevi who are candidates for re-excision

    Page :1112-1114

    Jaclyn N. Roland-McGowan, Steven Caleb Freeman, Wenelia Baghoomian, Bryan T. Carroll, Caroline Choi Kim, Clara Curiel-Lewandrowski, Emily Y. Chu, Erin L. Foster, Kelly Carter Nelson, Kevin P. White, Michael E. Ming, Rebecca I. Hartman, Sancy A. Leachman, Stephanie Mengden-Koon, Suephy C. Chen, Susan M. Swetter, Victor G. Prieto, Elizabeth Berry, Wesley Y. Yu

     
  • ·Medicaid formularies for rosacea treatment are often restrictive and show inconsistency in transparency and coverage

    Page :1115-1117

    Weston P. Lowry, Michael R. Nock, Jeffrey M. Cohen, John S. Barbieri

    
  • ·Establishing minimally important difference thresholds for lesion counts in acne clinical studies

    Page :1117-1119

    John S. Barbieri, Susan S. Ellenberg, Ann Tierney, Suzette Baez VanderBeek, Maryte Papadopoulos, Jennifer Mason, Anabel Mason, James Dattilo, David J. Margolis

    
  • ·High rates of potentially unnecessary topical antifungal prescribing in a large commercial health insurance claims database, United States

    Page :1119-1121

    Jeremy A.W. Gold, Kaitlin Benedict, Avrom S. Caplan, Shari R. Lipner, Dallas J. Smith

    Plan Plan
  • ·Efficacy of hedgehog pathway inhibitors as adjuvant in treating steroid-refractory sclerodermatous chronic graft-versus-host disease

    Page :1121-1123

    Andres Mendez-Hernandez, Ridhi Gupta, Sally Arai, Robert Lowsky, Bernice Kwong, Wen-Kai Weng

     
  • ·Abrocitinib interferes with the performance of T-SPOT.TB assay for latent tuberculosis reactivation: An in vitro study

    Page :1124-1125

    Yiting Li, Xi Tan, Shu Nie, Bin Chen, Chaoshuai Zhao, Ran Liu, Zhouwei Wu

     
  • ·Dupilumab and neuropsychiatric outcomes in pediatric atopic dermatitis: A real-world cohort analysis

    Page :1126-1128

    Maria Kaltchenko, Sarah Radtke, Elle Kim, Joy Wan

    
  • ·Higher odds of dupilumab prescriptions for Black patients with atopic dermatitis: Results of a retrospective study using DataDerm, the database of the American Academy of Dermatology

    Page :1128-1131

    Ramiro Rodriguez, Mindy D. Szeto, Jourdan Hydol-Smith, Colin Burnette, Arik Aninos, Toni Kaye, Lisa M. Schilling, Robert P. Dellavalle

    
  • ·Occupational formalin exposure from biopsy jars can be minimized by a modified collection procedure

    Page :1131-1132

    Julia Aires, Viseslav Tonkovic-Capin, M. Laird Forrest

     
  • ·Dupilumab treatment restores lesional and nonlesional skin barrier function in adults and adolescents with atopic dermatitis irrespective of the filaggrin genotype: Results from an open-label, healthy-control–matched, phase 4 clinical study (BALISTAD)

    Page :1132-1136

    Robert Bissonnette, Elena Goleva, Evgeny Berdyshev, Shannon Garcia, Marco Ramirez-Gama, Patricia A. Taylor, Gabriel Bologna, Amy H. Praestgaard, Lei Chen, Noah A. Levit, Joseph Zahn, Ana B. Rossi, Annie Zhang, Donald Y.M. Leung

    Plan Plan  
  • ·The presence of cutaneous lupus in systemic lupus erythematosus is associated with an increased risk of mental health disorders: a large-scale, retrospective cohort study

    Page :1136-1138

    Aaron Bao, Saloni Patel, Anjana Srikumar, Jun Kang

     
  • ·Comparing prescription drug saving platforms for dermatology: A cost analysis of Mark Cuban Cost Plus Drugs, GoodRx, and Amazon RxPass

    Page :1138-1141

    Nikhita J. Perry, John S. Barbieri

    
  • ·Glucagon-like peptide-1 receptor agonist medications and hair loss: A retrospective cohort study

    Page :1141-1143

    Olivia Burke, Brianna Sa, David Alvarez Cespedes, Andrea Sechi, Antonella Tosti

    
  • ·SCAR-ed by Antibiotics: A retrospective cohort study of severe cutaneous adverse reactions (SCAR) relative risk

    Page :1143-1145

    Zachary J.K. Neubauer, Ryan Chan, Amit Singal, Shari R. Lipner

    
  • ·Real-world experience of tralokinumab for atopic dermatitis: A 16-week multicenter retrospective study

    Page :1145-1148

    Siddhartha Sood, Marni Wiseman, Ahmed Bagit, Khalad Maliyar, Muskaan Sachdeva, Abrahim Abduelmula, Michelle James, Fernejoy Leung, Parbeer Grewal, Vimal H. Prajapati, Jensen Yeung

    
  • ·Analysis of epidemiology and health care utilization for tinea nigra, white piedra, and black piedra among 39.4 million commercially insured outpatients, United States

    Page :1148-1151

    Jeremy A.W. Gold, Kaitlin Benedict, Shari R. Lipner

    
  • ·Infection risk of rituximab monotherapy versus combination therapy with rituximab and mycophenolic acid in systemic sclerosis: A retrospective cohort study

    Page :1151-1153

    Joyce B. Kang, Katherine Nabel Smith, Emily M. Meara, MiJin Cho, Justin D. Silverman, Avery H. LaChance, Jeffrey S. Smith

     
  • ·Early inadequate response to biological agents portends treatment failure at 6 months in patients with psoriasis: A multicenter, prospective cohort study

    Page :1153-1156

    Yuxiong Jiang, Lingling Yao, Xiaoyuan Zhong, Dawei Huang, Yu Wang, Yifan Hu, Shuang Xu, Qian Yu, Ying Li, Jiajing Lu, Yuling Shi

     
  • ·Combination of oral minoxidil and bicalutamide for the treatment of female pattern hair loss in adolescents

    Page :1156-1157

    Nicole Yoong, Valerie Yii, Rodney Sinclair, Bevin Bhoyrul

     
  • ·Pediatric primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: A retrospective analysis and review of the literature

    Page :1157-1159

    Oluwaseyi Adeuyan, Celine M. Schreidah, Jeffrey W. Craig, Werner Kempf, Erika Morsia, Jose A. Plaza, Christina Mitteldorf, Alessandro Pileri, Larisa J. Geskin, Alejandro A. Gru

     
  • ·Treatment of androgenetic alopecia with low-dose oral minoxidil monotherapy compared with combination therapy with dutasteride or finasteride

    Page :1159-1161

    Ambika Nohria, Deesha Desai, Michelle Sikora, Akshay Pulavarty, Anna Brinks, Carli Needle, Avrom Caplan, Jerry Shapiro, Kristen Lo Sicco

    
  • ·Discrepancies in patch testing timing and outcomes: A retrospective analysis of the Pediatric Allergic Contact Dermatitis Registry

    Page :1161-1164

    Mykayla Sandler, Eun Jae Kim, Li-Chi Chen, JiaDe Yu

    

• JAAD Game Changers

  • ·JAAD Game Changers: Randomized controlled pilot study of the preoperative use of brimonidine 0.33% topical gel for hemostasis in Mohs micrographic surgery

    Page :1164

    Andrew Patterson

    

• Health Policy & Practice

  • ·High degree of variability and lack of transparency among private insurers for coverage of comprehensive patch testing

    Page :1165-1166

    William J. Nahm, Alexandra Flamm

    
  • ·A call to action regarding the Risk Evaluation and Mitigation Strategy program for brodalumab

    Page :1167-1169

    Milaan Shah, Psoriasis Expert Panel, Mark Lebwohl

    

• JAAD Game Changers

  • ·JAAD Game Changers: Utility of recorded guided imagery and relaxing music in reducing patient pain and anxiety, and surgeon anxiety, during cutaneous surgical procedures: A single-blinded randomized controlled trial

    Page :1169

    Eden Lake

    

• Dermatology Images

  • ·The morphological spectrum of cheilitis

    Page :1170-1175

    Biswanath Behera, Enzo Errichetti, Sonika Garg, Shreya K. Gowda, Vishal Thakur

     

• Humanities

  • ·Dermatologists carrying forward the legacy of Rudolph Virchow: Lessons learned from Dr Ernesto González-Martínez

    Page :1176-1178

    Kathyana P. Santiago Mangual, Eryn A. Patin, Arianne Shadi Kourosh

     

• Ethics Journal Club

  • ·Ethical dilemma of billing for pathology of cosmetically removed skin lesions

    Page :1179-1180

    Neelesh P. Jain, Christian Gronbeck, Albert E. Zhou, Jane M. Grant-Kels, Hao Feng

    
  • ·The ethics of depigmentation for vitiligo

    Page :1181-1182

    Akash Rau, Jane M. Grant-Kels

    
  • ·Ethical implications of no-show fees in dermatology: Balancing practice needs and patient concerns

    Page :1183-1184

    Alana L. Ferreira, Jeromy W. Gotschall, Jane M. Grant-Kels

    
  • ·Ethics of patient requests to amend medical records

    Page :1185-1186

    Albert E. Zhou, Jane M. Grant-Kels

    
  • ·Ethical impact of physician voices in the arena of societal discourse

    Page :1187-1188

    Shawn Afvari, Jane M. Grant-Kels

    

• JAAD Online

  • ·Hair removal through subcutaneous plane beyond the excision borders: A new way to prevent recurrences in hidradenitis suppurativa

    Page :e127

    Vaishnavi Verma, Ayush Jain, Somesh Gupta

    Plan Plan   
  • ·Use of a surgical hand immobilizer for nail surgery

    Page :e129

    Juan Jimenez-Cauhe, Francisco José Martínez-Ortega, Jesus Garcia-Silva

    Plan Plan  
  • ·Ultraviolet-enhanced ex vivo dermoscopy: A novel approach for demodicosis

    Page :e131

    Miriam Fernández-Parrado, Héctor Perandones-González, Elena Lucía Pinto-Pulido, Francisco José Rodríguez-Cuadrado, Elia Samaniego-González, Pablo Boixeda

    Plan Plan  
  • ·Response to Taylor et al, “Enhanced disease-specific survival in lentigo maligna melanoma patients treated with Mohs surgery over wide local excision: A retrospective cohort analysis of the Surveillance, Epidemiology, and End Results database”

    Page :e133

    Robert A. Swerlick, Yin Li, Adewole S. Adamson

    
  • ·Lasers for medical indications: Port-wine birthmarks and beyond

    Page :e135

    Murad Alam

    
  • ·Bridging the gap in acne vulgaris research for skin of color patients

    Page :e137

    Lauren Fleshner, Katie Roster, Sarah Balboul, Shari R. Lipner

    
  • ·Response to Fleshner et al, “Bridging the gap in acne vulgaris research for skin of color patients: Response to: “Assessing the inclusion of post-inflammatory hyperpigmentation outcomes in acne vulgaris clinical trials”

    Page :e139

    Alyssa Swearingen, Christine Olagun-Samuel, Prince Adotama

    
  • ·Response to Kang et al, “Efficacy of low-dose oral minoxidil in the management of anticancer therapy-induced alopecia in patients with breast cancer: A retrospective cohort study”

    Page :e141

    Caitlin A. Kearney, Anna L. Brinks, Carli D. Needle, Jerry Shapiro, Mario E. Lacouture, Kristen I. Lo Sicco

    
  • ·Response to Kearney et al, “Response to Kang et al, ‘Efficacy of low-dose oral minoxidil in the management of anticancer therapy-induced alopecia in patients with breast cancer: A retrospective cohort study’”

    Page :e143

    Jeewoo Kang, Ji Won Lee, Ohsang Kwon

    
  • ·Comments on the increased risk of hidradenitis suppurativa in patients with human papillomavirus infection

    Page :e145

    Tai-Li Chen, Tsung-Hsien Chang

    
  • ·Response to Chen et al, “Comments on the increased risk of hidradenitis suppurativa in patients with human papillomavirus infection”

    Page :e147

    Hui-Chin Chang, Shao-Wei Lo, Christine Hsu, Shiu-Jau Chen, Torsten Zuberbier, Shuo-Yan Gau

    
  • ·Comments on “impact of delay of diagnosis of pyoderma gangrenosum on healing outcomes and health care utilization: A prospective cohort study”

    Page :e149

    Peng-Yu Chen, Sui-Qing Cai, Zhuang-Li Tang

    
  • ·Response to “Comments on “Impact of delay of diagnosis of pyoderma gangrenosum on healing outcomes and healthcare utilization: a prospective cohort study””

    Page :e151

    Olivia M. Haddadin, Emile Latour, Alex G. Ortega-Loayza

     
  • ·Response to Sood et al’s “Systemic Janus kinase inhibitor treatment for vitiligo: An evidence-based review”

    Page :e155

    Caitlin A. Kearney, Carli D. Needle, Anna L. Brinks, Daniel Gutierrez, Kristen I. Lo Sicco

    
  • ·Response to Vera et al’s “Interleukin-23 inhibition associates with lower incidence of cardiovascular risk factor type diseases compared to biologic naïve patients with psoriasis: A retrospective cohort study”

    Page :e157

    Wei-Wei Liu, James Cheng-Chung Wei

    
  • ·Response to Liu et al., “Response to Ormaza Vera et al. “Interleukin 23 inhibition associates with lower incidence of cardiovascular risk factor type diseases compared to biologic-naïve patients with psoriasis: A retrospective cohort study””

    Page :e159

    Ana Ormaza Vera, Clinton W. Enos

    
  • ·Limitations and risks of custom GPTs in dermatology. Comment on “ReconGPT: A novel artificial intelligence tool and its potential use in post-Mohs reconstructive decision-making”

    Page :e161

    Jinge Wang, Zachary Zinn, Dong Xu, Gangqing Hu

    Plan Plan  
  • ·Response to Wang et al's limitations and risks of custom GPTs in dermatology. Comment on “ReconGPT: A novel artificial intelligence tool and its potential use in post-Mohs reconstructive decision-making”

    Page :e163

    Neil Jairath, Sophia Manduca, Syril Keena T. Que

    
  • ·Rook’s Textbook of Dermatology, 10th Edition

    Page :e165

    Dirk M. Elston

    
  • ·May 2025 iotaderma (#375)

    Page :e167

    Robert I. Rudolph